vs

Side-by-side financial comparison of COMPUGEN LTD (CGEN) and MAYS J W INC (MAYS). Click either name above to swap in a different company.

MAYS J W INC is the larger business by last-quarter revenue ($5.2M vs $3.5M, roughly 1.5× COMPUGEN LTD). MAYS J W INC runs the higher net margin — -9.8% vs -410.1%, a 400.4% gap on every dollar of revenue. On growth, MAYS J W INC posted the faster year-over-year revenue change (-7.7% vs -61.8%). MAYS J W INC produced more free cash flow last quarter ($-1.7M vs $-18.8M).

Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big compan...

J.W. Mays, Inc. is a real estate firm based in Brooklyn, New York, United States. From 1927 until 1988 the company ran a chain of discount department stores in the area surrounding New York City referred to as Mays, with stores located in three of New York City's five boroughs, Long Island, and Putnam County. At its height as a retailer, the firm had 5000 employees working in 9 stores during the early 1970s.

CGEN vs MAYS — Head-to-Head

Bigger by revenue
MAYS
MAYS
1.5× larger
MAYS
$5.2M
$3.5M
CGEN
Growing faster (revenue YoY)
MAYS
MAYS
+54.1% gap
MAYS
-7.7%
-61.8%
CGEN
Higher net margin
MAYS
MAYS
400.4% more per $
MAYS
-9.8%
-410.1%
CGEN
More free cash flow
MAYS
MAYS
$17.1M more FCF
MAYS
$-1.7M
$-18.8M
CGEN

Income Statement — Q2 FY2025 vs Q2 FY2026

Metric
CGEN
CGEN
MAYS
MAYS
Revenue
$3.5M
$5.2M
Net Profit
$-14.5M
$-509.0K
Gross Margin
Operating Margin
-475.1%
-13.7%
Net Margin
-410.1%
-9.8%
Revenue YoY
-61.8%
-7.7%
Net Profit YoY
-54.7%
-222.8%
EPS (diluted)
$-0.16
$-0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CGEN
CGEN
MAYS
MAYS
Q1 26
$5.2M
Q4 25
$5.3M
Q3 25
$5.7M
Q2 25
$3.5M
$5.6M
Q1 25
$5.6M
Q4 24
$5.5M
Q3 24
$5.5M
Q2 24
$9.3M
$5.4M
Net Profit
CGEN
CGEN
MAYS
MAYS
Q1 26
$-509.0K
Q4 25
$-334.0K
Q3 25
$-92.0K
Q2 25
$-14.5M
$86.8K
Q1 25
$-157.7K
Q4 24
$26.7K
Q3 24
$-31.1K
Q2 24
$-9.4M
$-84.9K
Gross Margin
CGEN
CGEN
MAYS
MAYS
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
60.5%
Operating Margin
CGEN
CGEN
MAYS
MAYS
Q1 26
-13.7%
Q4 25
-9.3%
Q3 25
-2.4%
Q2 25
-475.1%
2.0%
Q1 25
-3.2%
Q4 24
0.9%
Q3 24
-1.5%
Q2 24
-128.5%
-2.9%
Net Margin
CGEN
CGEN
MAYS
MAYS
Q1 26
-9.8%
Q4 25
-6.4%
Q3 25
-1.6%
Q2 25
-410.1%
1.5%
Q1 25
-2.8%
Q4 24
0.5%
Q3 24
-0.6%
Q2 24
-101.4%
-1.6%
EPS (diluted)
CGEN
CGEN
MAYS
MAYS
Q1 26
$-0.25
Q4 25
$-0.17
Q3 25
$-0.04
Q2 25
$-0.16
$0.04
Q1 25
$-0.08
Q4 24
$0.01
Q3 24
$-0.02
Q2 24
$-0.10
$-0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CGEN
CGEN
MAYS
MAYS
Cash + ST InvestmentsLiquidity on hand
$35.3M
$434.4K
Total DebtLower is stronger
$3.2M
Stockholders' EquityBook value
$50.3M
$51.9M
Total Assets
$106.5M
$88.4M
Debt / EquityLower = less leverage
0.06×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CGEN
CGEN
MAYS
MAYS
Q1 26
$434.4K
Q4 25
$2.2M
Q3 25
$748.6K
Q2 25
$35.3M
$2.3M
Q1 25
$1.5M
Q4 24
$2.3M
Q3 24
$1.2M
Q2 24
$44.6M
$1.2M
Total Debt
CGEN
CGEN
MAYS
MAYS
Q1 26
$3.2M
Q4 25
$3.2M
Q3 25
$3.2M
Q2 25
$3.3M
Q1 25
$3.3M
Q4 24
$3.5M
Q3 24
$3.9M
Q2 24
Stockholders' Equity
CGEN
CGEN
MAYS
MAYS
Q1 26
$51.9M
Q4 25
$52.4M
Q3 25
$52.8M
Q2 25
$50.3M
$52.9M
Q1 25
$52.8M
Q4 24
$52.9M
Q3 24
$52.9M
Q2 24
$58.3M
$52.9M
Total Assets
CGEN
CGEN
MAYS
MAYS
Q1 26
$88.4M
Q4 25
$88.7M
Q3 25
$88.0M
Q2 25
$106.5M
$87.9M
Q1 25
$88.3M
Q4 24
$88.5M
Q3 24
$89.5M
Q2 24
$110.2M
$90.4M
Debt / Equity
CGEN
CGEN
MAYS
MAYS
Q1 26
0.06×
Q4 25
0.06×
Q3 25
0.06×
Q2 25
0.06×
Q1 25
0.06×
Q4 24
0.07×
Q3 24
0.07×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CGEN
CGEN
MAYS
MAYS
Operating Cash FlowLast quarter
$-18.6M
$-730.1K
Free Cash FlowOCF − Capex
$-18.8M
$-1.7M
FCF MarginFCF / Revenue
-530.8%
-32.9%
Capex IntensityCapex / Revenue
6.5%
18.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$794.1K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CGEN
CGEN
MAYS
MAYS
Q1 26
$-730.1K
Q4 25
$1.9M
Q3 25
$2.5M
Q2 25
$-18.6M
$1.9M
Q1 25
$-383.4K
Q4 24
$1.8M
Q3 24
$1.4M
Q2 24
$39.7M
$2.0M
Free Cash Flow
CGEN
CGEN
MAYS
MAYS
Q1 26
$-1.7M
Q4 25
$1.5M
Q3 25
$128.3K
Q2 25
$-18.8M
$868.4K
Q1 25
$-586.2K
Q4 24
$1.3M
Q3 24
$-1.0M
Q2 24
$39.7M
$789.9K
FCF Margin
CGEN
CGEN
MAYS
MAYS
Q1 26
-32.9%
Q4 25
28.8%
Q3 25
2.3%
Q2 25
-530.8%
15.4%
Q1 25
-10.4%
Q4 24
24.2%
Q3 24
-19.1%
Q2 24
428.3%
14.7%
Capex Intensity
CGEN
CGEN
MAYS
MAYS
Q1 26
18.9%
Q4 25
7.8%
Q3 25
42.3%
Q2 25
6.5%
18.8%
Q1 25
3.6%
Q4 24
8.3%
Q3 24
45.2%
Q2 24
0.4%
21.9%
Cash Conversion
CGEN
CGEN
MAYS
MAYS
Q1 26
Q4 25
Q3 25
Q2 25
22.22×
Q1 25
Q4 24
67.62×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons